In conclusion, the levels of endothelial injury biomarkers, as well as VEGF and IL-18, in SLE patients during standard treatment could be suppressed by a combinatory treatment with the traditional Chinese medicine LC. This evidence concerns the gene VEGFA and systemic lupus erythematosus.